Physician

Harry James Mccarty, MD

According to 2025 Medicare claims, Harry Mccarty, MD (NPI: 1265550131) practices radiation oncology in the Huntsville, AL market, with the plurality of this provider's patient population coming from Madison, AL. This provider's primary affiliated billing organization is CENTER FOR CANCER CARE LLC (NPI: 1982629648; TIN: 63-1185834) and primary practice location at 35805-2606.

Mccarty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 774 traditional Medicare patients, billed 6,184 HCPCS/CPT codes, and received $966,943 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 310 prescription claims across 151 beneficiaries totaling $15,597 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). 2022 DME data shows 28 claims. Open Payments data shows 2 records totaling $65. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,220,589 to $966,943. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $17,332 to $15,597. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,058	8,698	$1,220,589
2016	1,042	8,676	$1,211,061
2017	1,061	8,759	$1,314,586
2018	1,110	8,947	$1,434,214
2019	975	7,510	$1,245,633
2020	835	7,290	$1,319,584
2021	806	6,353	$1,305,760
2022	720	5,476	$842,891
2023	777	5,870	$843,155
2024	774	6,184	$966,943

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	111	372	$17,332
2016	133	414	$21,350
2017	139	349	$18,594
2018	131	364	$15,877
2019	141	411	$11,100
2020	136	352	$11,525
2021	112	255	$6,444
2022	101	277	$9,406
2023	108	234	$8,699
2024	151	310	$15,597

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	32	$5,032
2016	N/R	N/R	N/R
2017	N/R	32	$4,150
2018	N/R	31	$3,834
2019	N/R	13	$1,494
2020	N/R	N/R	N/R
2021	N/R	29	$4,183
2022	N/R	28	$3,977
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	274	1,216	$259
G6012	Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev	130	428	$166
77427	Radiation treatment management, 5 treatment sessions	156	443	$150
77014	Ct guidance for insertion of radiation therapy fields	386	1,518	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	178	203	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	68	4,515	$940
Bicalutamide	Bicalutamide	21	605	$474
Dutasteride	Dutasteride	11	330	$277
Venlafaxine Hcl Er	Venlafaxine Hcl	11	570	$238
Levothyroxine Sodium	Levothyroxine Sodium	19	1,170	$116

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$65	Novocure Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Harry James Mccarty, MD?

Tedicare shows public-source Medicare data for Harry James Mccarty, MD (NPI 1265550131), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harry James Mccarty, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Harry James Mccarty, MD?

Harry James Mccarty, MD is linked to CENTER FOR CANCER CARE LLC (billing NPI 1982629648) in the available physician profile data.

Does Harry James Mccarty, MD have Open Payments data?

Harry James Mccarty, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.